Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lechin, Fuad
and
van der Dijs, Bertha
2005.
Noradrenergic hypothesis of schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 29,
Issue. 5,
p.
777.
Buckley, Peter F
and
Shendarkar, Nitin
2005.
Treatment-refractory schizophrenia.
Current Opinion in Psychiatry,
Vol. 18,
Issue. 2,
p.
165.
Stip, Emmanuel
Chouinard, Sylvie
and
Boulay, Luc Jean
2005.
On the trail of a cognitive enhancer for the treatment of schizophrenia.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 29,
Issue. 2,
p.
219.
Scheperjans, Filip
Grefkes, Christian
Palomero-Gallagher, Nicola
Schleicher, Axel
and
Zilles, Karl
2005.
Subdivisions of human parietal area 5 revealed by quantitative receptor autoradiography: a parietal region between motor, somatosensory, and cingulate cortical areas.
NeuroImage,
Vol. 25,
Issue. 3,
p.
975.
Peuskens, Joseph
Demily, Caroline
and
Thibaut, Florence
2005.
Treatment of cognitive dysfunction in schizophrenia.
Clinical Therapeutics,
Vol. 27,
Issue. ,
p.
S25.
Müller, Ulrich
Clark, Luke
Lam, Minh L.
Moore, Rebecca M.
Murphy, C. Louise
Richmond, Nicola K.
Sandhu, Ranbir S.
Wilkins, Ingrid A.
Menon, David K.
Sahakian, Barbara J.
and
Robbins, Trevor W.
2005.
Lack of effects of guanfacine on executive and memory functions in healthy male volunteers.
Psychopharmacology,
Vol. 182,
Issue. 2,
p.
205.
Keltner, Norman L.
and
Grant, Joan S.
2006.
Smoke, Smoke, Smoke That Cigarette.
Perspectives In Psychiatric Care,
Vol. 42,
Issue. 4,
p.
256.
Kohler, Christian G.
Martin, Elizabeth A.
Kujawski, Evan
Bilker, Warren
Gur, Raquel E.
and
Gur, Ruben C.
2007.
No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.
Cognitive Neuropsychiatry,
Vol. 12,
Issue. 5,
p.
412.
Ji, Xiao-Hua
Ji, Jin-Zhao
Zhang, Hui
and
Li, Bao-Ming
2008.
Stimulation of α2-Adrenoceptors Suppresses Excitatory Synaptic Transmission in the Medial Prefrontal Cortex of Rat.
Neuropsychopharmacology,
Vol. 33,
Issue. 9,
p.
2263.
Boulinguez, Philippe
Ballanger, Bénédicte
Granjon, Lionel
and
Benraiss, Abdelrhani
2009.
The paradoxical effect of warning on reaction time: Demonstrating proactive response inhibition with event-related potentials.
Clinical Neurophysiology,
Vol. 120,
Issue. 4,
p.
730.
Keltner, Norman L.
and
Lillie, Karen
2009.
Biological Perspectives�Nicotinic Receptors: Implications for Psychiatric Care.
Perspectives in Psychiatric Care,
Vol. 45,
Issue. 2,
p.
151.
Chemerinski, Eran
and
Siever, Larry J.
2010.
Schizophrenia.
p.
62.
Stenberg, Jan-Henry
Terevnikov, Viatcheslav
Joffe, Marina
Tiihonen, Jari
Tchoukhine, Evgueni
Burkin, Mark
and
Joffe, Grigori
2010.
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study.
The International Journal of Neuropsychopharmacology,
Vol. 13,
Issue. 04,
p.
433.
Decamp, Emmanuel
Clark, Kathryn
and
Schneider, Jay S.
2011.
Effects of the alpha‐2 adrenoceptor agonist guanfacine on attention and working memory in aged non‐human primates.
European Journal of Neuroscience,
Vol. 34,
Issue. 6,
p.
1018.
Sathyasaikumar, K. V.
Stachowski, E. K.
Wonodi, I.
Roberts, R. C.
Rassoulpour, A.
McMahon, R. P.
and
Schwarcz, R.
2011.
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia.
Schizophrenia Bulletin,
Vol. 37,
Issue. 6,
p.
1147.
Raveendranathan, Dhanya
Rao, Mukund G
Varambally, Shivarama
Venkatasubramanian, Ganesan
and
Gangadhar, Bangalore N
2012.
Atomoxetine-Induced Vocal Tics in a Patient With Schizophrenia.
The Journal of Neuropsychiatry and Clinical Neurosciences,
Vol. 24,
Issue. 4,
p.
E45.
Cantilena, Louis
Kahn, Roberta
Duncan, Connie C.
Li, Shou-Hua
Anderson, Ann
and
Elkashef, Ahmed
2012.
Safety of Atomoxetine in Combination With Intravenous Cocaine in Cocaine-Experienced Participants.
Journal of Addiction Medicine,
Vol. 6,
Issue. 4,
p.
265.
Kishi, Taro
Mukai, Tomohiko
Matsuda, Yuki
Moriwaki, Masatsugu
and
Iwata, Nakao
2013.
Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials.
Journal of Psychiatric Research,
Vol. 47,
Issue. 11,
p.
1557.
Wang, Chang-Hong
Li, Yan
Yang, Jun
Su, Lin-Yan
Geng, Yao-Guo
Li, Hao
Wang, Ji-Kang
and
Mu, Jun-Lin
2013.
A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia.
Schizophrenia Research,
Vol. 144,
Issue. 1-3,
p.
129.
Chemerinski, Eran
Triebwasser, Joseph
Roussos, Panos
and
Siever, Larry J.
2013.
Schizotypal Personality Disorder.
Journal of Personality Disorders,
Vol. 27,
Issue. 5,
p.
652.